Bernhard H - Search Results

1

Induction of tumor-cell lysis by bi-specific antibody recognizing ganglioside GD2 and T-cell antigen CD3.

Bernhard H, Karbach J, Strittmatter W, Meyer zum Büschenfelde KH, Knuth A. Bernhard H, et al. Int J Cancer. 1993 Sep 30;55(3):465-70. doi: 10.1002/ijc.2910550324. Int J Cancer. 1993. PMID: 8375931

2

Immunorecognition of different ganglioside epitopes on human normal and melanoma tissues.

Bernhard H, Roth S, Bauerschmitz J, Meyer zum Büschenfelde KH, Dippold W. Bernhard H, et al. Int J Cancer. 1992 Jun 19;51(4):568-72. doi: 10.1002/ijc.2910510411. Int J Cancer. 1992. PMID: 1376299

3

Ganglioside GD3 shedding by human malignant melanoma cells.

Bernhard H, Meyer zum Büschenfelde KH, Dippold WG. Bernhard H, et al. Int J Cancer. 1989 Jul 15;44(1):155-60. doi: 10.1002/ijc.2910440127. Int J Cancer. 1989. PMID: 2744885

4

Induction of tumour cell lysis by a bispecific antibody recognising epidermal growth factor receptor (EGFR) and CD3.

Knuth A, Bernhard H, Jäger E, Wölfel T, Karbach J, Jäggle C, Strittmatter W, Meyer zum Büschenfelde KH. Knuth A, et al. Among authors: bernhard h. Eur J Cancer. 1994;30A(8):1103-7. doi: 10.1016/0959-8049(94)90466-9. Eur J Cancer. 1994. PMID: 7654439

5

Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.

Bernhard H, Karbach J, Wölfel T, Busch P, Störkel S, Stöckle M, Wölfel C, Seliger B, Huber C, Meyer zum Büschenfelde KH, et al. Bernhard H, et al. Int J Cancer. 1994 Dec 15;59(6):837-42. doi: 10.1002/ijc.2910590621. Int J Cancer. 1994. PMID: 7989126

6

Immunological response to intrathecal and systemic treatment with ganglioside antibody R-24 in patients with malignant melanoma.

Dippold W, Bernhard H, Meyer zum Büschenfelde KH. Dippold W, et al. Among authors: bernhard h. Eur J Cancer. 1994;30A(2):137-44. doi: 10.1016/0959-8049(94)90073-6. Eur J Cancer. 1994. PMID: 8155384

7

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens.

Jäeger E, Bernhard H, Romero P, Ringhoffer M, Arand M, Karbach J, Ilsemann C, Hagedorn M, Knuth A. Jäeger E, et al. Among authors: bernhard h. Int J Cancer. 1996 Apr 10;66(2):162-9. doi: 10.1002/(SICI)1097-0215(19960410)66:2<162::AID-IJC4>3.0.CO;2-0. Int J Cancer. 1996. PMID: 8603805

8

Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma.

Bernhard H, Maeurer MJ, Jäger E, Wölfel T, Schneider J, Karbach J, Seliger B, Huber C, Storkus WS, Lotze MT, Meyer zum Büschenfelde KH, Knuth A. Bernhard H, et al. Scand J Immunol. 1996 Sep;44(3):285-92. doi: 10.1046/j.1365-3083.1996.d01-304.x. Scand J Immunol. 1996. PMID: 8795723

9

Tumor associated antigens in human renal cell carcinoma: MHC restricted recognition by cytotoxic T lymphocytes.

Bernhard H, Jäger E, Maeurer MJ, Meyer zum Büschenfelde KH, Knuth A. Bernhard H, et al. Tissue Antigens. 1996 Jul;48(1):22-31. doi: 10.1111/j.1399-0039.1996.tb02601.x. Tissue Antigens. 1996. PMID: 8864171

10

Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates.

Karbach J, Gnjatic S, Biskamp M, Atmaca A, Weidmann E, Brandt K, Wahle C, Bernhard H, Knuth A, Jäger E. Karbach J, et al. Among authors: bernhard h. Cancer Immunol Res. 2014 May;2(5):404-9. doi: 10.1158/2326-6066.CIR-13-0200. Epub 2014 Feb 5. Cancer Immunol Res. 2014. PMID: 24795353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters